Searchable abstracts of presentations at key conferences on calcified tissues

ba0004p185 | (1) | ICCBH2015

The effect of iron chelators on bone health in patients with thalassemia

Fung Ellen , Luo Nan , Gildengorin Ginny , Lal Ashutosh

Thalassemia (Thal) is a genetic disorder of hemoglobin synthesis. In its most severe form patients require chronic blood transfusions to sustain life leading to iron overload unless excess iron is removed by chelators. Deferasirox (DFX) and deferoxamine (DFO) are the two most common chelators. DFX has recently been shown to reduce osteoclast activity in vitro.Objective: To explore the association between chelation therapy, bone density and verte...